Suchergebnisse - "Naiki, Kayoko"

PubPharm (51)

21

NS5A-P32 deletion as a factor involved in virologic failure in patients receiving glecaprevir and pibrentasvir

enthalten in: Journal of gastroenterology | 2019

von Uemura, H. | Uchida, Y. | Kouyama, J. | +9

22

Significance of NS5B Substitutions in Genotype 1b Hepatitis C Virus Evaluated by Bioinformatics Analysis

enthalten in: Scientific reports | 2018

von Uchida, Y. | Nakamura, S. | Kouyama, J. | +11

23

Retreatment with sofosbuvir/ledipasvir with or without lead-in interferon-β injections in patients infected with genotype 1b hepatitis C virus after unsuccessful daclatasvir/asunaprevir therapy

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2018

von Uemura, H. | Uchida, Y. | Kouyama, J. | +17

24

Chronic hepatitis caused by hepatitis C virus showing a discrepancy between serogroup and genotype because of intergenotypic 2b/1b recombination : A pitfall in antiviral therapy with direct-acting antivirals

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2018

von Kurata, H. | Uchida, Y. | Kouyama, J. | +11

25

Serum asunaprevir concentrations showing correlation with the extent of liver fibrosis as a factor inducing liver injuries in patients with genotype-1b hepatitis C virus receiving daclatasvir plus asunaprevir therapy

enthalten in: PloS one | 2018

von Uchida, Y. | Naiki, K. | Kouyama, J. | +8

26

Chronic hepatitis caused by hepatitis C virus showing a discrepancy between serogroup and genotype because of intergenotypic 2b/1b recombination : A pitfall in antiviral therapy with direct‐acting antivirals

enthalten in: Hepatology Research | 2018

von Kurata, H. | Uchida, Y. | Kouyama, J. | +11

27

"Reversi-type virologic failure" involved in the development of non-structural protein 5A resistance-associated variants (RAVs) in patients with genotype 1b hepatitis C carrying no signature RAVs at baseline

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2017

von Uchida, Y. | Kouyama, J. | Naiki, K. | +5

28

Sequential therapy consisting of glucocorticoid infusions followed by granulocyte-monocyte absorptive apheresis in patients with severe alcoholic hepatitis

enthalten in: Journal of gastroenterology | 2017

von Watanabe, K. | Uchida, Y. | Sugawara, K. | +4

29

“Reversi-Type Virologic Failure” Involved in the Development of NS5A-RAVs in Patients with Genotype 1b HCV Carrying No Signature RAVs at Baseline

enthalten in: Hepatology research | 2017

von Uchida, Y. | Kouyama, J. | Naiki, K. | +5

30

Sequential therapy consisting of glucocorticoid infusions followed by granulocyte–monocyte absorptive apheresis in patients with severe alcoholic hepatitis

enthalten in: Journal of gastroenterology | 2017

von Watanabe, K. | Uchida, Y. | Sugawara, K. | +4